Tool Icon

VUNO

4.7 (29 votes)
VUNO

Tags

Healthcare-AI Medical-Imaging Predictive-Analytics Clinical-Orchestration SaaS

Integrations

  • AWS HealthImaging
  • HL7 FHIR R5
  • DICOM / PACS
  • Epic / Cerner (EHR)
  • NVIDIA MONAI

Pricing Details

  • VUNO has transitioned to a SaaS-centric model in 2026.
  • Pricing is typically based on annual modular subscriptions or per-study volume for cloud-native diagnostic suites.

Features

  • FDA-cleared DeepCARS™ Cardiac Prediction
  • Cloud-native DeepBrain® Volumetric Analysis
  • Chest X-ray Prioritization (Triage)
  • HL7 FHIR R5 Interoperability
  • Medical ASR (DeepASR®) integration
  • Multi-modal Diagnostic Orchestration

Description

VUNO Med System Architecture Assessment

As of January 2026, VUNO Med functions as a global medical AI orchestration layer, following its successful FDA clearance for cardiovascular and radiological suites. The architecture centers on the VUNO Med-DeepCARS™ and VUNO Med-DeepBrain® engines, which leverage a unified processing pipeline to analyze both pixel-based DICOM data and time-series physiological signals 📑. The system has moved to a Cloud-First SaaS model, utilizing AWS HealthImaging for low-latency delivery of neuro-quantification reports 📑.

Medical Imaging & Vital Sign Orchestration

The platform utilizes a modular, microservices-based architecture to manage high-concurrency diagnostic tasks.

  • DeepCARS™ (Vital Signs): FDA-cleared engine that monitors BP, HR, RR, and BT via temporal transformers to predict in-hospital cardiac arrest (IHCA) up to 24 hours in advance 📑.
  • DeepBrain® (SaaS MRI): Cloud-native brain parcellation engine that performs volumetric analysis of 100+ brain regions in <60 seconds, now featuring native RAG-based clinical summary generation 📑.
  • Chest X-ray Triage: Automated prioritization of urgent findings (e.g., pneumothorax, pleural effusion) directly within the PACS worklist, optimized for 2026 clinical reimbursement standards 📑.

⠠⠉⠗⠑⠁⠞⠑⠙⠀⠃⠽⠀⠠⠁⠊⠞⠕⠉⠕⠗⠑⠲⠉⠕⠍

Operational Scenarios

  • Emergency Cardiac Prediction: Input: Vital sign telemetry (HR, RR, BP, BT) via HL7 FHIR R5 → Process: DeepCARS™ temporal analysis against 2.5M+ patient-hour baseline data → Output: Risk-score alert (0-100) integrated into the nurse's dashboard and mobile workstation 📑.
  • Dementia Screening Workflow: Input: 3D T1-weighted brain MRI via DICOM STOW-RS to VUNO.CLOUD → Process: DeepBrain® automated atrophy quantification with AWS HealthImaging-accelerated reconstruction → Output: Volumetric report with percentile ranking and longitudinal comparison PDF 📑.

Evaluation Guidance

Technical evaluators should verify the following architectural characteristics:

  • SaaS Latency (MRI): Benchmark the end-to-end turnaround time for 3D MRI quantification when using cloud-native reconstruction vs. legacy on-premise local nodes 🧠.
  • FHIR R5 Ingest Pipeline: Organizations should validate the stability of bidirectional data flow between VUNO.CLOUD and specific EMR versions (Epic R5 / Cerner 2026) for real-time risk scores 🌑.
  • Medical ASR Accuracy: Verify the error rate of VUNO Med-DeepASR® in specialized surgical environments where nomenclature differs from standard radiology dictation 🌑.

Release History

Autonomous Patient Guard 2026 2025-12

Year-end update: Release of the Autonomous Patient Guard. Real-time AI monitoring hub for ICU units that manages patient alert prioritization.

GenAI Medical Liaison 2024-11

Integration of generative AI to summarize multi-modal diagnostic data. Automatically creates cohesive patient summaries from imaging and vital signs.

DeepASR Voice Integration 2024-04

General availability of VUNO Med-DeepASR. Medical voice-to-text recognition with 95%+ accuracy for real-time radiology reporting.

Hanimed Acquisition & Pathology 2023-09

Strategic move into digital pathology. Launched VUNO Med-Pathology for whole-slide imaging (WSI) analysis in oncology.

DeepBrain Expansion 2022-10

Enhanced MRI analysis with DeepBrain. Automated brain atrophy quantification to assist in early Alzheimer's and dementia diagnosis.

VUNO Med-DeepCARS Launch 2021-08

Introduction of a vital-sign based predictive AI. Analyzes heart rate, blood pressure, and respiration to predict cardiac arrest in hospital patients.

VUNO Med-Chest X-ray (FDA/CE) 2020-06

Global expansion: Received CE marking and FDA clearance for Chest X-ray analysis. Automated detection of lung nodules and pneumonia.

VUNO Med-BoneAge (Initial Milestone) 2018-05

First MFDS (South Korea) clearance for an AI medical device. Focused on automating bone age assessment for pediatric growth tracking.

Tool Pros and Cons

Pros

  • Faster, accurate diagnoses
  • Comprehensive data integration
  • Improved workflow
  • Reduced errors
  • AI-powered analysis
  • Enhanced patient care
  • Optimized radiology workflows
  • Multi-imaging support

Cons

  • Potential data bias
  • IT integration complexity
  • Implementation costs
Chat